Clinical efficiency of panavir in therapy of chronicle papillomavirus infections of cervix uteri

Cover Page

Abstract


This research is devoted to determination of the clinical efficacy of Panavir in the combined therapy of the uterine cervix diseases associated with human papillomavirus (HPV). The article presents data of the complex examination of 59 patients. Patients with diagnosed 16th, 18th, 31st, 33rd types of HPV underwent destructive methods of treatment of the cervix followed by Panavir. The efficacy of Panavir was estimated by PCR in 3, 6 and 12 months from the beginning of treatment and it was 84,7%. Antiviral therapy permits to prevent recurrence of papillomavirus infection of the cervix uteri.

P I Kovchur

Petrozavodsk State University

Email: pkovchur@mail.ru
Кафедра госпитальной хирургии с курсом онкологии; Петрозаводский государственный университет; Petrozavodsk State University

I E Bahlaev

Petrozavodsk State University

Email: bie@sampo.ru <mailto:bie@sampo.ru>
Кафедра госпитальной хирургии с курсом онкологии; Петрозаводский государственный университет; Petrozavodsk State University

Views

Abstract - 157

PDF (Russian) - 30


Copyright (c) 2011 Ковчур П.И., Бахлаев И.Е.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.